A009290 logo

Kwang Dong Pharmaceutical Co., Ltd. Stock Price

KOSE:A009290 Community·₩304.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A009290 Share Price Performance

₩0
-5420.00 (-100.00%)
₩0
-5420.00 (-100.00%)
Price ₩0

A009290 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

Kwang Dong Pharmaceutical Co., Ltd. Key Details

₩1.7t

Revenue

₩1.4t

Cost of Revenue

₩299.0b

Gross Profit

₩278.0b

Other Expenses

₩21.0b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
571.98
18.01%
1.26%
40.2%
View Full Analysis

About A009290

Founded
1963
Employees
1032
CEO
Sung-Won Choi
WebsiteView website
www.ekdp.com

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs. In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

Recent A009290 News & Updates

Recent updates

No updates